T1	Pharmacological_substance 10 20	Gabapentin
N1000 	Reference T1 MeSH:C040029	Gabapentin
T2	Disorder 47 65	hypomanic features
T3	Pharmacological_substance 112 122	gabapentin
N1001 	Reference T3 MeSH:C040029	gabapentin
T4	Pharmacological_substance 124 127	GBP
N1002 	Reference T4 MeSH:C040029	GBP
T5	Disorder 233 241	epilepsy
N1 	Reference T5 UMLS:C0014544	epilepsy
T6	Disorder 317 328	psychiatric
T8	Pharmacological_substance 601 604	GBP
N1003 	Reference T8 MeSH:C040029	GBP
T9	Disorder 646 653	seizure
N2 	Reference T9 UMLS:C0036572	seizure
T16	Disorder 156 180	behavioural side effects
T17	Pharmacological_substance 198 201	GBP
N1004 	Reference T17 MeSH:C040029	GBP
T18	Disorder 261 274	paraesthesiae
T19	Disorder 332 352	behavioural disorder
N3 	Reference T19 UMLS:C0004930	behavioural disorder
T7	Pharmacological_substance 719 722	GBP
N1005 	Reference T7 MeSH:C040029	GBP
T20	Disorder 401 409	euphoria
T11	Disorder 29 41	mood changes
N4 	Reference T11 UMLS:C0085633	mood changes
T13	Subject 88 98	two adults
T25	Disorder 454 472	pressure of speech
N5 	Reference T25 UMLS:C0233718	pressure of speech
T26	Disorder 477 501	decreased need for sleep
N6 	Reference T26 UMLS:C1862911	decreased need for sleep
T27	Disorder 386 399	elevated mood
N7 	Reference T27 UMLS:C0233479	elevated mood
T28	Disorder 415 431	increased energy
N8 	Reference T28 UMLS:C0455769	increased energy
T30	Subject 736 742	adults
T31	Speculation_cue 695 703	possible
T33	Disorder 354 372	Abnormal behaviour
N9 	Reference T33 UMLS:C0233514	Abnormal behaviour
T34	Disorder 606 625	Behavioural changes
N10 	Reference T34 UMLS:C0233514	Behavioural changes
T36	Coreferring_mention 664 668	They
T38	Subject 570 581	One patient
T35	Subject 69 75	adults
